Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abex Pharmaceuticals is a South African-based pharmaceutical company that specializes in the development, registration, and commercialization of generic and specialized medicines. The company focuses on therapeutic areas including oncology, central nervous system disorders, and cardiovascular health, providing cost-effective alternatives to originator brands. Abex manages a comprehensive suite of services including regulatory affairs, market access, and distribution within the Southern African region. Their portfolio includes a significant range of oncology treatments, aiming to improve patient outcomes through increased affordability. The company operates as a private entity and maintains strategic partnerships for the manufacturing and supply of its product range.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abex Pharmaceuticals.